Related Experiment Videos
Adhesion molecule monoclonal antibodies inhibit experimental autoimmune thyroiditis
R A Metcalfe1, N Tandon, T Tamatani
1Department of Medicine, University of Sheffield, U.K.
Immunology
|November 1, 1993
Summary
Monoclonal antibodies targeting lymphocyte function-associated antigen-1 (LFA-1) reduced autoantibody production and thyroid inflammation in experimental autoimmune thyroiditis. Both LFA-1 and intercellular adhesion molecule-1 (ICAM-1) antibodies inhibited T cell responses.
Area of Science:
- Immunology
- Endocrinology
- Autoimmunity
Background:
- Thyroid autoimmunity involves complex immune responses.
- Adhesion molecules play a critical role in immune cell trafficking and function.
Purpose of the Study:
- To investigate the role of intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1) in experimental autoimmune thyroiditis.
- To assess the therapeutic potential of monoclonal antibodies targeting these adhesion molecules.
Main Methods:
- Experimental autoimmune thyroiditis was induced in rats by immunization with thyroglobulin.
- Rats were administered monoclonal antibodies against ICAM-1 and LFA-1.
- In vitro assays evaluated T cell proliferation and thyroid cell killing.
Main Results:
- The antibody against LFA-1 significantly reduced thyroglobulin autoantibody production.
- Both ICAM-1 and LFA-1 antibodies markedly decreased lymphocytic infiltration in the thyroid.
- In vitro, both antibodies inhibited T cell proliferation, while only LFA-1 antibody reduced thyroid cell killing.
Conclusions:
- Monoclonal antibodies targeting ICAM-1 and LFA-1 demonstrate potential in modulating experimental autoimmune thyroiditis.
- LFA-1 appears to be a key target for reducing both autoantibody production and thyroid inflammation.